COMMENTARY: An early invasive strategy reduced death or MI better than a conservative strategy in unstable angina and non-STEMI at advanced age
- Anticoagulants and Myocardial Infarction. Goldman, Lee; Feinstein, Alvan R. // Annals of Internal Medicine;Jan79, Vol. 90 Issue 1, p92
Comments on the problems of pooling clinical trial data on the value of anticoagulation in acute myocardial infarction. Criteria for pooling clinical trial data; Ancillary therapeutic issues in the applicability of pooled old data to current medical practice.
- Percutaneous coronary intervention in patients with active bleeding or high bleeding risk. Nguyen, James; Nguyen, Thach // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Mar2013, Vol. 13 Issue 2, p165
There isa lack of evidence from randomized clinical trials (RCT) supporting percutaneous coronary intervention (PCI) in patients with high bleeding risk or active bleeding. The management decisions are based on extrapolation of subgroups data in RCTs or experts' opinions. Bleeding in the...
- Combining aspirin with antithrombotic agents. Sung, Joseph J. Y. // BMJ: British Medical Journal (International Edition);10/7/2006, Vol. 333 Issue 7571, p712
The author reflects on the increased use of aspirin and other antithrombotic agents to prevent myocardial and cerebrovascular disease in the United States. Aspirin can cause mucosal ulceration and upper gastrointestinal bleeding and should be used for the shortest duration, minimizing bleeding....
- LONG-TERM USE OF ANTICOAGULANTS FOLLOWING ACUTE MYOCARDIAL INFARCTION. Cosby, Richard S.; Herman, Lawrence M.; Talbot, John C.; Mayo, Mary // Angiology;Jan1964, Vol. 15 Issue 1, p57
Focuses on the beneficial effect of long-term anticoagulant therapy on patients suffering from myocardial infarction. Improvement on the quality of life; Reduction on the risks of bleeding episodes; Description on the physical condition of the patients.
- Therapy for Patients with Acute Coronary Syndromes – New Opportunities. Gibbons, Raymond J.; Fuster, Valentin // New England Journal of Medicine;4/6/2006, Vol. 354 Issue 14, p1524
The article focuses on the authors' views on therapy for patients with acute coronary syndromes. The authors refer to the definition of acute coronary syndromes as myocardial infarction with ST-segment elevation, myocardial infarction without ST-segment elevation, and unstable angina, which...
- COMMENTARY: Fondaparinux reduced death or reinfarction in acute ST-segment elevation myocardial infarction. Borzak, Steven // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p29
The article comments on the study related to the use of the drug fondaparinux to treat patients with acute ST-segment elevation myocardial infarction (STEMI). In the study fondaparinux was found useful in reducing death. These trials support the use of anticoagulant therapy in patients with...
- Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease. // New England Journal of Medicine;7/19/2007, Vol. 357 Issue 3, p217
Background: Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the role of oral anticoagulant agents in the prevention of cardiovascular complications in...
- Blood transfusions linked with mortality in patients with STEMI. // Hem/Onc Today;3/10/2009, Vol. 10 Issue 5, p58
The article discusses research being done on the link between blood transfusions and mortality in patients with ST-Segment Elevation Myocardial Infarction (STEMI), published in the 2009 issue of the "Journal of the American College of Cardiology."
- FOCUS: 10 g/dL transfusion strategy in postsurgical patients offers no improvement in MI or death. Raible, Eric; Rusk, Judy; Southall, Jennifer // Hem/Onc Today;12/10/2009, Vol. 10 Issue 23, p43
The article discusses research which demonstrated that a 10 gram/deciliter blood transfusion strategy to stabilize postsurgical hemoglobin levels did not result to improved myocardial infarction (MI) or mortaliy, presented by Jeffrey L. Carson at the American Heart Association Scientific...